Eli Lilly & Co on Wednesday reported strong revenue growth in the third quarter and a return to profit, as it develop ...
Eli Lilly & Co on Monday announced it has appointed Lucas Montarce as chief financial officer with immediate effect. ...
Eli Lilly & Co on Thursday raised annual guidance once again, as it reported double-digit growth in the second quarte ...
Patients taking Eli Lilly & Co's new drug Mounjaro achieved significantly greater weight loss than those on Novo Nord ...
Alphabet Inc on Wednesday said Anat Ashkenazi will become the company's new chief financial officer from the end of J ...
Eli Lilly & Co announced on Wednesday that it has come to an agreement with Totality Medispa over the latter's claim ...
Eli Lilly & Co on Tuesday lifted its full-year sales outlook as it reported increased demand for its weight-loss and ...
Eli Lilly & Co's highly anticipated Alzheimer's drug has been held back for further review by regulators, the US phar ...
Eli Lilly & Co on Tuesday reported higher fourth-quarter sales, with sales of recently-launched weight loss drugs hel ...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 81.83 | 81.83 | 81.83 | 1136 | 81.83 | DE |
4 | 0 | 0 | 81.83 | 81.83 | 81.83 | 1428 | 81.83 | DE |
12 | 0 | 0 | 81.83 | 81.83 | 81.83 | 827 | 81.83 | DE |
26 | 0 | 0 | 81.83 | 81.83 | 81.83 | 734 | 81.83 | DE |
52 | 0 | 0 | 81.83 | 81.83 | 81.83 | 602 | 81.83 | DE |
156 | 0 | 0 | 81.83 | 81.83 | 81.83 | 261 | 81.83 | DE |
260 | 0 | 0 | 81.83 | 81.83 | 81.83 | 192 | 81.83 | DE |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관